Joseph Ashwal, MD, knew a good deal when he saw one.
The family physician wanted to take the lead on starting a patient-centered medical home (PCMH) model for his 25-physician practice in Frederick, Md., after reading a nearly 100-page treatise from the area's largest private payer.
The program from CareFirst BlueCross BlueShield -- like so many others -- would pay a bonus for spending extra time with their sicker patients. The money would cover a care coordinator nurse to help oversee these patients' care.
That nurse would help identify the practice's most needy patients, help develop a care plan with their physician, and ensure that the patient saw it through.
"That nurse does a lot of work so the physicians don't have to do it," Ashwal told MedPage Today.
The program -- the Total Care and Cost Improvement Program -- has been a game-changer for Ashwal and his practice, Frederick Primary Care Associates, yielding more than a 20% increase in payments from CareFirst last summer for the group's success during 2011 in lowering spending by keeping patients out of the hospital and emergency departments.
Read the full story here: http://bit.ly/14eaA5m
Source: MedPage Today
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More